[Atypical antipsychotics in elderly patients with dementia]

Area of Science:

• Geriatric Medicine
• Psychopharmacology
• Neurology

Background:

• Behavioral and psychological symptoms of dementia (BPSD) are common and often treated with antipsychotics.
• Elderly individuals with dementia using atypical antipsychotics face increased risks of cerebrovascular events and mortality.

Purpose of the Study:

• To evaluate the efficacy and safety of antipsychotic medications for BPSD in dementia patients.
• To compare atypical and conventional antipsychotics regarding their effects and adverse event profiles.

Main Methods:

• Systematic review of available literature on antipsychotic use in dementia with BPSD.
• Analysis of efficacy data for BPSD symptom management.
• Assessment of serious adverse event profiles and mortality risks.

Main Results:

• Atypical antipsychotics demonstrate a modest effect on BPSD but are associated with potentially serious side effects.
• Conventional antipsychotics show less favorable effects and worse adverse event profiles compared to atypical ones.
• Increased risk of cerebrovascular adverse events and mortality linked to atypical antipsychotic use in elderly dementia patients.

Conclusions:

• Antipsychotic use for BPSD in dementia should be limited to short-term treatment of severe symptoms.
• Non-pharmacological interventions should be prioritized as the first-line treatment for BPSD.
• Careful consideration of risks versus benefits is crucial when prescribing antipsychotics for dementia-related behavioral symptoms.